<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="31739" end="31744" sStart="31546" offset="193" sid="r7.1.use.v.0921" wn="1" wnkey="use%2:34:01::" text="After spinning to dryness in a clinical centrifuge equipped with plate carriers (Beckman), the arrays were scanned in an Axon Laboratories (Palo Alto, CA) scanner using 532 nm and 635 nm lasers." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="8990" end="8994" sStart="null" offset="66" sid="r11.true.j.0465" wn="2" wnkey="true%5:00:00:accurate:00" text="The dashed lines represent the log 10 of the true ratios of the antigen concentrations in the two mixes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="27135" end="27146" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Antibodies and antigens that were provided in glycerol solutions were &lt;b&gt;transferred&lt;/b&gt; to a glycerol-free, phosphate-buffered saline (PBS) solution (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na" />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="28534" end="28545" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="They were &lt;b&gt;transferred&lt;/b&gt; immediately to a 3% non-fat milk/PBS/0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="143" end="148" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The need for technologies that allow highly parallel quantitation of specific proteins in a &lt;b&gt;rapid&lt;/b&gt;, low-cost and low-sample-volume format has become increasingly apparent with the growing recognition of the importance of global approaches to molecular characterization of physiology, development, and disease [ 1, 2]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="143" end="148" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The need for technologies that allow highly parallel quantitation of specific proteins in a &lt;b&gt;rapid&lt;/b&gt;, low-cost and low-sample-volume format has become increasingly apparent with the growing recognition of the importance of global approaches to molecular characterization of physiology, development, and disease [ 1, 2]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19279" end="19284" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The spots in the right &lt;b&gt;image&lt;/b&gt; are much less clear against the high background, but the fluorescent signals are still measurable." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19279" end="19284" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The spots in the right &lt;b&gt;image&lt;/b&gt; are much less clear against the high background, but the fluorescent signals are still measurable." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19279" end="19284" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The spots in the right &lt;b&gt;image&lt;/b&gt; are much less clear against the high background, but the fluorescent signals are still measurable." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19279" end="19284" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The spots in the right &lt;b&gt;image&lt;/b&gt; are much less clear against the high background, but the fluorescent signals are still measurable." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21873" end="21879" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The background is very similar between the &lt;b&gt;images&lt;/b&gt;, but the fluorescence intensity of the spots is greatly reduced as the partial and absolute concentration of the cognate antibodies decreases." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19065" end="19071" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The &lt;b&gt;images&lt;/b&gt; at the top of Figure 6show details from one array in each set." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19279" end="19284" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="The spots in the right &lt;b&gt;image&lt;/b&gt; are much less clear against the high background, but the fluorescent signals are still measurable." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="16489" end="16497" sStart="null" offset="138" sid="r11.function.n.0535" wn="4" wnkey="function%1:24:01::" text="Similarly, we plotted the percentage of antibodies and antigens that provided satisfactory quantitative accuracy as a function of analyte concentration (Figure 5b)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21478" end="21482" sStart="null" offset="59" sid="r9.fold.v.0094" wn="2147483646" wnkey="null" text="The six antibody mixes were added to either a 10-fold or a 100-fold excess (by total protein mass) of FCS." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21478" end="21482" sStart="null" offset="59" sid="r9.fold.v.0094" wn="2147483646" wnkey="null" text="The six antibody mixes were added to either a 10-fold or a 100-fold excess (by total protein mass) of FCS." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21598" end="21602" sStart="null" offset="52" sid="r9.fold.v.0768" wn="2147483645" wnkey="null" text="The high-concentration set was diluted 10-fold, so that the total protein concentration was equivalent in the two sets of protein mixtures." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21478" end="21482" sStart="null" offset="59" sid="r9.fold.v.0094" wn="2147483645" wnkey="null" text="The six antibody mixes were added to either a 10-fold or a 100-fold excess (by total protein mass) of FCS." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="19004" end="19008" sStart="null" offset="273" sid="r9.fold.v.0870" wn="" wnkey="null" text="We therefore investigated the effect of protein background on quantitation, by adding varying concentrations of fetal calf serum (FCS) to the set of six antigen mixes, increasing the overall protein concentrations by 10-fold and 100-fold before labeling and detection (Figure 6)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21478" end="21482" sStart="null" offset="59" sid="r9.fold.v.0094" wn="" wnkey="null" text="The six antibody mixes were added to either a 10-fold or a 100-fold excess (by total protein mass) of FCS." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="7" wnkey="color%1:07:01::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7374" end="7379" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" text="At progressively lower concentrations, the &lt;b&gt;color&lt;/b&gt; of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="7403" end="7411" sStart="null" offset="82" sid="r9.appear.v.0798" wn="1" wnkey="appear%2:39:00::" text="At progressively lower concentrations, the color of the spots appeared more yellow, and at the lowest concentration of 1.6 ng/ml (Figure 1panel 3 for anti-Flag and Figure 1panel 6 for anti-IgG), the spots appeared green." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="18820" end="18826" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="We therefore investigated the effect of protein background on quantitation, by &lt;b&gt;adding&lt;/b&gt; varying concentrations of fetal calf serum (FCS) to the set of six antigen mixes, increasing the overall protein concentrations by 10-fold and 100-fold before labeling and detection (Figure 6)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="30444" end="30449" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="The Cy3-labeled reference mix was divided equally among the Cy5-labeled mixes, and PBS was &lt;b&gt;added&lt;/b&gt; to each to achieve 25 ?l for each array." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2001-2-2-research0004.anc" start="21457" end="21462" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="The six antibody mixes were &lt;b&gt;added&lt;/b&gt; to either a 10-fold or a 100-fold excess (by total protein mass) of FCS." />
  </sentences>
</list>